TP53 interacts with and affects other tumor suppressor activities including CDKN2A (cyclin-dependent kinase inhibitor 2A) [112], BRCA1 [113], and PTEN (phosphatase and tensin homolog [114] (Figure 1). This evidence concerns the gene TP53 and neoplasm.